A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer Invasive Nos
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Hoffmann-La Roche|Roche Farma, S.A